Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 124

1.

The Selection of Comparators for Randomized Controlled Trials of Health-Related Behavioral Interventions: Recommendations of an NIH Expert Panel.

Freedland KE, King AC, Ambrosius WT, Mayo-Wilson E, Mohr DC, Czajkowski SM, Thabane L, Collins LM, Rebok GW, Treweek SP, Cook TD, Edinger JD, Stoney CM, Campo RA, Young-Hyman D, Riley WT; National Institutes of Health Office of Behavioral and Social Sciences Research Expert Panel on Comparator Selection in Behavioral and Social Science Clinical Trials.

J Clin Epidemiol. 2019 Feb 28. pii: S0895-4356(18)30539-0. doi: 10.1016/j.jclinepi.2019.02.011. [Epub ahead of print] Review.

PMID:
30826377
2.

Effect of losartan and fish oil on plasma IL-6 and mobility in older persons. The ENRGISE Pilot randomized clinical trial.

Pahor M, Anton SD, Beavers DP, Cauley JA, Fielding RA, Kritchevsky SB, Leeuwenburgh C, Lewis KH, Liu CK, Lovato LC, Lu J, Manini TM, McDermott MM, Miller ME, Newman AB, Radziszewska B, Stowe CL, Tracy RP, Walkup MP, Wu SS, Ambrosius WT; ENRGISE study investigators.

J Gerontol A Biol Sci Med Sci. 2018 Dec 12. doi: 10.1093/gerona/gly277. [Epub ahead of print]

PMID:
30541065
3.

PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT.

Ginsberg C, Craven TE, Chonchol MB, Cheung AK, Sarnak MJ, Ambrosius WT, Killeen AA, Raphael KL, Bhatt UY, Chen J, Chertow GM, Freedman BI, Oparil S, Papademetriou V, Wall BM, Wright CB, Ix JH, Shlipak MG; SPRINT Research Group.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1816-1824. doi: 10.2215/CJN.05390518. Epub 2018 Nov 13.

PMID:
30425104
4.

Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.

Beddhu S, Chertow GM, Greene T, Whelton PK, Ambrosius WT, Cheung AK, Cutler J, Fine L, Boucher R, Wei G, Zhang C, Kramer H, Bress AP, Kimmel PL, Oparil S, Lewis CE, Rahman M, Cushman WC.

J Am Heart Assoc. 2018 Sep 18;7(18):e009326. doi: 10.1161/JAHA.118.009326.

5.

Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT.

Malhotra R, Craven T, Ambrosius WT, Killeen AA, Haley WE, Cheung AK, Chonchol M, Sarnak M, Parikh CR, Shlipak MG, Ix JH; SPRINT Research Group.

Am J Kidney Dis. 2019 Jan;73(1):21-30. doi: 10.1053/j.ajkd.2018.07.015. Epub 2018 Oct 2.

PMID:
30291012
6.

Pulse wave velocity and central aortic pressure in systolic blood pressure intervention trial participants.

Supiano MA, Lovato L, Ambrosius WT, Bates J, Beddhu S, Drawz P, Dwyer JP, Hamburg NM, Kitzman D, Lash J, Lustigova E, Miracle CM, Oparil S, Raj DS, Weiner DE, Taylor A, Vita JA, Yunis R, Chertow GM, Chonchol M.

PLoS One. 2018 Sep 26;13(9):e0203305. doi: 10.1371/journal.pone.0203305. eCollection 2018.

7.

The Enabling Reduction of Low-Grade Inflammation in Seniors (ENRGISE) Pilot Study: Screening Methods and Recruitment Results.

Cauley JA, Manini TM, Lovato L, Talton J, Anton SD, Domanchuk K, Kennedy K, Stowe CL, Walkup M, Fielding RA, Kritchevsky SB, McDermott MM, Newman AB, Ambrosius WT, Pahor M; ENRGISE Investigators.

J Gerontol A Biol Sci Med Sci. 2018 Sep 8. doi: 10.1093/gerona/gly204. [Epub ahead of print]

PMID:
30202946
8.

Effect of Exercise Modality During Weight Loss on Bone Health in Older Adults With Obesity and Cardiovascular Disease or Metabolic Syndrome: A Randomized Controlled Trial.

Beavers KM, Walkup MP, Weaver AA, Lenchik L, Kritchevsky SB, Nicklas BJ, Ambrosius WT, Stitzel JD, Register TC, Shapses SA, Marsh AP, Rejeski WJ.

J Bone Miner Res. 2018 Dec;33(12):2140-2149. doi: 10.1002/jbmr.3555. Epub 2018 Aug 7.

PMID:
30088288
9.

Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: A systematic review and meta-analysis.

Custodero C, Mankowski RT, Lee SA, Chen Z, Wu S, Manini TM, Hincapie Echeverri J, Sabbà C, Beavers DP, Cauley JA, Espeland MA, Fielding RA, Kritchevsky SB, Liu CK, McDermott MM, Miller ME, Tracy RP, Newman AB, Ambrosius WT, Pahor M, Anton SD.

Ageing Res Rev. 2018 Sep;46:42-59. doi: 10.1016/j.arr.2018.05.004. Epub 2018 May 25. Review.

10.

Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial).

Shapiro BP, Ambrosius WT, Blackshear JL, Cushman WC, Whelton PK, Oparil S, Beddhu S, Dwyer JP, Gren LH, Kostis WJ, Lioudis M, Pisoni R, Rosendorff C, Haley WE; SPRINT Research Group*.

Hypertension. 2018 Jun;71(6):1064-1074. doi: 10.1161/HYPERTENSIONAHA.117.10646. Epub 2018 Apr 30.

PMID:
29712745
11.

A new modeling and inference approach for the Systolic Blood Pressure Intervention Trial outcomes.

Yang S, Ambrosius WT, Fine LJ, Bress AP, Cushman WC, Raj DS, Rehman S, Tamariz L.

Clin Trials. 2018 Jun;15(3):305-312. doi: 10.1177/1740774518769865. Epub 2018 Apr 19.

PMID:
29671345
12.

Response by Soliman et al to Letters Regarding Article, "Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial)".

Soliman EZ, Ambrosius WT, Lewis CE.

Circulation. 2018 Mar 20;137(12):1300-1301. doi: 10.1161/CIRCULATIONAHA.117.031849. No abstract available.

PMID:
29555717
13.

Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial).

Johnson KC, Whelton PK, Cushman WC, Cutler JA, Evans GW, Snyder JK, Ambrosius WT, Beddhu S, Cheung AK, Fine LJ, Lewis CE, Rahman M, Reboussin DM, Rocco MV, Oparil S, Wright JT Jr; SPRINT Research Group.

Hypertension. 2018 May;71(5):848-857. doi: 10.1161/HYPERTENSIONAHA.117.10479. Epub 2018 Mar 12.

PMID:
29531173
14.

Lack of Longitudinal Association Between Thiazolidinediones and Incidence and Progression of Diabetic Eye Disease: The ACCORD Eye Study.

Gower EW, Lovato JF, Ambrosius WT, Chew EY, Danis RP, Davis MD, Goff DC Jr, Greven CM; ACCORD Study Group.

Am J Ophthalmol. 2018 Mar;187:138-147. doi: 10.1016/j.ajo.2017.12.007. Epub 2017 Dec 22.

15.

Association of Accelerometry-Measured Physical Activity and Cardiovascular Events in Mobility-Limited Older Adults: The LIFE (Lifestyle Interventions and Independence for Elders) Study.

Cochrane SK, Chen SH, Fitzgerald JD, Dodson JA, Fielding RA, King AC, McDermott MM, Manini TM, Marsh AP, Newman AB, Pahor M, Tudor-Locke C, Ambrosius WT, Buford TW; LIFE Study Research Group.

J Am Heart Assoc. 2017 Dec 2;6(12). pii: e007215. doi: 10.1161/JAHA.117.007215.

16.

Change in health-related quality of life and social cognitive outcomes in obese, older adults in a randomized controlled weight loss trial: Does physical activity behavior matter?

Fanning J, Walkup MP, Ambrosius WT, Brawley LR, Ip EH, Marsh AP, Rejeski WJ.

J Behav Med. 2018 Jun;41(3):299-308. doi: 10.1007/s10865-017-9903-6. Epub 2017 Nov 22.

PMID:
29168052
17.

Effect of Exercise Type During Intentional Weight Loss on Body Composition in Older Adults with Obesity.

Beavers KM, Ambrosius WT, Rejeski WJ, Burdette JH, Walkup MP, Sheedy JL, Nesbit BA, Gaukstern JE, Nicklas BJ, Marsh AP.

Obesity (Silver Spring). 2017 Nov;25(11):1823-1829. doi: 10.1002/oby.21977.

18.

Factors Mediating Outcome After Stroke: Gender, Thrombolysis, and Their Interaction.

Lee SJ, Heo SH, Ambrosius WT, Bushnell CD.

Transl Stroke Res. 2018 Jun;9(3):267-273. doi: 10.1007/s12975-017-0579-6. Epub 2017 Oct 24.

PMID:
29067622
19.

A Comparison of Self-report Indices of Major Mobility Disability to Failure on the 400-m Walk Test: The LIFE Study.

Chen H, Rejeski WJ, Gill TM, Guralnik J, King AC, Newman A, Blair SN, Conroy D, Liu C, Manini TM, Pahor M, Ambrosius WT, Miller ME; LIFE Study.

J Gerontol A Biol Sci Med Sci. 2018 Mar 14;73(4):513-518. doi: 10.1093/gerona/glx153.

20.

Imputation of Gait Speed for Noncompleters in the 400-Meter Walk: Application to the Lifestyle Interventions for Elders Study.

Chen H, Ambrosius WT, Murphy TE, Fielding R, Pahor M, Santanasto A, Tudor-Locke C, Jack Rejeski W, Miller ME; LIFE Study.

J Am Geriatr Soc. 2017 Dec;65(12):2566-2571. doi: 10.1111/jgs.15078. Epub 2017 Sep 8.

21.

ENabling Reduction of Low-grade Inflammation in SEniors Pilot Study: Concept, Rationale, and Design.

Manini TM, Anton SD, Beavers DP, Cauley JA, Espeland MA, Fielding RA, Kritchevsky SB, Leeuwenburgh C, Lewis KH, Liu C, McDermott MM, Miller ME, Tracy RP, Walston JD, Radziszewska B, Lu J, Stowe C, Wu S, Newman AB, Ambrosius WT, Pahor M; ENRGISE Pilot study investigators.

J Am Geriatr Soc. 2017 Sep;65(9):1961-1968. doi: 10.1111/jgs.14965. Epub 2017 Jul 22.

22.

Association Between Structured Physical Activity and Sedentary Time in Older Adults.

Wanigatunga AA, Ambrosius WT, Rejeski WJ, Gill TM, Glynn NW, Tudor-Locke C, Manini TM.

JAMA. 2017 Jul 18;318(3):297-299. doi: 10.1001/jama.2017.7203. No abstract available.

23.

The Comprehensive Post-Acute Stroke Services (COMPASS) study: design and methods for a cluster-randomized pragmatic trial.

Duncan PW, Bushnell CD, Rosamond WD, Jones Berkeley SB, Gesell SB, D'Agostino RB Jr, Ambrosius WT, Barton-Percival B, Bettger JP, Coleman SW, Cummings DM, Freburger JK, Halladay J, Johnson AM, Kucharska-Newton AM, Lundy-Lamm G, Lutz BJ, Mettam LH, Pastva AM, Sissine ME, Vetter B.

BMC Neurol. 2017 Jul 17;17(1):133. doi: 10.1186/s12883-017-0907-1.

24.

Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).

Soliman EZ, Ambrosius WT, Cushman WC, Zhang ZM, Bates JT, Neyra JA, Carson TY, Tamariz L, Ghazi L, Cho ME, Shapiro BP, He J, Fine LJ, Lewis CE; SPRINT Research Study Group.

Circulation. 2017 Aug 1;136(5):440-450. doi: 10.1161/CIRCULATIONAHA.117.028441. Epub 2017 May 16. Erratum in: Circulation. 2017 Aug 1;136(5):e136.

25.

Effect of Metabolic Syndrome on the Mobility Benefit of a Structured Physical Activity Intervention-The Lifestyle Interventions and Independence for Elders Randomized Clinical Trial.

Botoseneanu A, Chen H, Ambrosius WT, Allore HG, Anton S, Folta SC, King AC, Nicklas BJ, Spring BJ, Strotmeyer ES, Gill TM; LIFE Study Group.

J Am Geriatr Soc. 2017 Jun;65(6):1244-1250. doi: 10.1111/jgs.14793. Epub 2017 Mar 28.

26.

Community Weight Loss to Combat Obesity and Disability in At-Risk Older Adults.

Rejeski WJ, Ambrosius WT, Burdette JH, Walkup MP, Marsh AP.

J Gerontol A Biol Sci Med Sci. 2017 Oct 12;72(11):1547-1553. doi: 10.1093/gerona/glw252.

27.

Let's Not SPRINT to Judgment About New Blood Pressure Goals.

Lewis CE, Johnson KC, Rahman M, Sink KM, Ambrosius WT.

Ann Intern Med. 2016 Dec 20;165(12):889. doi: 10.7326/L16-0441. No abstract available.

PMID:
27992902
28.

Cardiovascular Events in a Physical Activity Intervention Compared With a Successful Aging Intervention: The LIFE Study Randomized Trial.

Newman AB, Dodson JA, Church TS, Buford TW, Fielding RA, Kritchevsky S, Beavers D, Pahor M, Stafford RS, Szady AD, Ambrosius WT, McDermott MM; LIFE Study Group.

JAMA Cardiol. 2016 Aug 1;1(5):568-74. doi: 10.1001/jamacardio.2016.1324.

29.

A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

SPRINT Research Group, Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT.

N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939. Epub 2015 Nov 9. Erratum in: N Engl J Med. 2017 Dec 21;377(25):2506.

30.

Insulin Dose and Cardiovascular Mortality in the ACCORD Trial.

Siraj ES, Rubin DJ, Riddle MC, Miller ME, Hsu FC, Ismail-Beigi F, Chen SH, Ambrosius WT, Thomas A, Bestermann W, Buse JB, Genuth S, Joyce C, Kovacs CS, O'Connor PJ, Sigal RJ, Solomon S; ACCORD Investigators.

Diabetes Care. 2015 Nov;38(11):2000-8. doi: 10.2337/dc15-0598. Epub 2015 Oct 13.

31.

Effects of TZD Use and Discontinuation on Fracture Rates in ACCORD Bone Study.

Schwartz AV, Chen H, Ambrosius WT, Sood A, Josse RG, Bonds DE, Schnall AM, Vittinghoff E, Bauer DC, Banerji MA, Cohen RM, Hamilton BP, Isakova T, Sellmeyer DE, Simmons DL, Shibli-Rahhal A, Williamson JD, Margolis KL.

J Clin Endocrinol Metab. 2015 Nov;100(11):4059-66. doi: 10.1210/jc.2015-1215. Epub 2015 Aug 25.

32.

Assessing Walking Activity in Older Adults: Development and Validation of a Novel Computer-Animated Assessment Tool.

Marsh AP, Janssen JA, Ip EH, Barnard RT, Ambrosius WT, Brubaker PR, Burdette JH, Sheedy JL, Rejeski WJ.

J Gerontol A Biol Sci Med Sci. 2015 Dec;70(12):1555-61. doi: 10.1093/gerona/glv101. Epub 2015 Aug 10.

33.

Correction: Light intensity physical activity and sedentary behavior in relation to body mass index and grip strength in older adults: cross-sectional findings from the Lifestyle Interventions and Independence for Elders (LIFE) study.

Bann D, Hire D, Manini T, Cooper R, Botoseneanu A, McDermott MM, Pahor M, Glynn NW, Fielding R, King AC, Church T, Ambrosius WT, Gill TM.

PLoS One. 2015 Apr 15;10(4):e0126063. doi: 10.1371/journal.pone.0126063. eCollection 2015.

34.

Association of objectively measured physical activity with cardiovascular risk in mobility-limited older adults.

Fitzgerald JD, Johnson L, Hire DG, Ambrosius WT, Anton SD, Dodson JA, Marsh AP, McDermott MM, Nocera JR, Tudor-Locke C, White DK, Yank V, Pahor M, Manini TM, Buford TW; LIFE Study Research Group.

J Am Heart Assoc. 2015 Feb 18;4(2). pii: e001288. doi: 10.1161/JAHA.114.001288.

35.

Light Intensity physical activity and sedentary behavior in relation to body mass index and grip strength in older adults: cross-sectional findings from the Lifestyle Interventions and Independence for Elders (LIFE) study.

Bann D, Hire D, Manini T, Cooper R, Botoseneanu A, McDermott MM, Pahor M, Glynn NW, Fielding R, King AC, Church T, Ambrosius WT, Gill TM; LIFE Study Group.

PLoS One. 2015 Feb 3;10(2):e0116058. doi: 10.1371/journal.pone.0116058. eCollection 2015. Erratum in: PLoS One. 2015;10(4):e0126063. Gill, Thomas [corrected to Gill, Thomas M].

36.

Prevalence of metabolic syndrome and its association with physical capacity, disability, and self-rated health in Lifestyle Interventions and Independence for Elders Study participants.

Botoseneanu A, Ambrosius WT, Beavers DP, de Rekeneire N, Anton S, Church T, Folta SC, Goodpaster BH, King AC, Nicklas BJ, Spring B, Wang X, Gill TM; LIFE Study Groups.

J Am Geriatr Soc. 2015 Feb;63(2):222-32. doi: 10.1111/jgs.13205. Epub 2015 Jan 30.

37.

The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Hugenschmidt CE, Lovato JF, Ambrosius WT, Bryan RN, Gerstein HC, Horowitz KR, Launer LJ, Lazar RM, Murray AM, Chew EY, Danis RP, Williamson JD, Miller ME, Ding J.

Diabetes Care. 2014 Dec;37(12):3244-52. doi: 10.2337/dc14-0502. Epub 2014 Sep 5.

38.

The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study.

Chew EY, Davis MD, Danis RP, Lovato JF, Perdue LH, Greven C, Genuth S, Goff DC, Leiter LA, Ismail-Beigi F, Ambrosius WT; Action to Control Cardiovascular Risk in Diabetes Eye Study Research Group.

Ophthalmology. 2014 Dec;121(12):2443-51. doi: 10.1016/j.ophtha.2014.07.019. Epub 2014 Aug 29.

39.

The degree of retinopathy is equally predictive for renal and macrovascular outcomes in the ACCORD Trial.

Mottl AK, Pajewski N, Fonseca V, Ismail-Beigi F, Chew E, Ambrosius WT, Greven C, Schubart U, Buse J.

J Diabetes Complications. 2014 Nov-Dec;28(6):874-9. doi: 10.1016/j.jdiacomp.2014.07.001. Epub 2014 Jul 12.

40.

Application of random forests methods to diabetic retinopathy classification analyses.

Casanova R, Saldana S, Chew EY, Danis RP, Greven CM, Ambrosius WT.

PLoS One. 2014 Jun 18;9(6):e98587. doi: 10.1371/journal.pone.0098587. eCollection 2014.

41.

The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).

Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, Fine LJ, Goff DC Jr, Johnson KC, Killeen AA, Lewis CE, Oparil S, Reboussin DM, Rocco MV, Snyder JK, Williamson JD, Wright JT Jr, Whelton PK; SPRINT Study Research Group.

Clin Trials. 2014 Oct;11(5):532-46. doi: 10.1177/1740774514537404. Epub 2014 Jun 5. Erratum in: Clin Trials. 2017 Apr;14(2):222.

42.

Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial.

Pahor M, Guralnik JM, Ambrosius WT, Blair S, Bonds DE, Church TS, Espeland MA, Fielding RA, Gill TM, Groessl EJ, King AC, Kritchevsky SB, Manini TM, McDermott MM, Miller ME, Newman AB, Rejeski WJ, Sink KM, Williamson JD; LIFE study investigators.

JAMA. 2014 Jun 18;311(23):2387-96. doi: 10.1001/jama.2014.5616.

43.

Characteristics associated with informed consent for genetic studies in the ACCORD trial.

Simons-Morton DG, Chan JC, Kimel AR, Linz PE, Stowe CL, Summerson J, Ambrosius WT.

Contemp Clin Trials. 2014 Jan;37(1):155-64. doi: 10.1016/j.cct.2013.12.002. Epub 2013 Dec 17.

44.

Effects of randomization to intensive glucose control on adverse events, cardiovascular disease, and mortality in older versus younger adults in the ACCORD Trial.

Miller ME, Williamson JD, Gerstein HC, Byington RP, Cushman WC, Ginsberg HN, Ambrosius WT, Lovato L, Applegate WB; ACCORD Investigators.

Diabetes Care. 2014;37(3):634-43. doi: 10.2337/dc13-1545. Epub 2013 Oct 29.

45.

The Cooperative Lifestyle Intervention Program-II (CLIP-II): design and methods.

Marsh AP, Janssen JA, Ambrosius WT, Burdette JH, Gaukstern JE, Morgan AR, Nesbit BA, Paolini JB, Sheedy JL, Rejeski WJ.

Contemp Clin Trials. 2013 Nov;36(2):382-93. doi: 10.1016/j.cct.2013.08.006. Epub 2013 Aug 23.

46.

Effect of an 18-month physical activity and weight loss intervention on body composition in overweight and obese older adults.

Beavers KM, Beavers DP, Nesbit BA, Ambrosius WT, Marsh AP, Nicklas BJ, Rejeski WJ.

Obesity (Silver Spring). 2014 Feb;22(2):325-31. doi: 10.1002/oby.20607. Epub 2013 Sep 20.

47.

Independent and combined effects of physical activity and weight loss on inflammatory biomarkers in overweight and obese older adults.

Beavers KM, Ambrosius WT, Nicklas BJ, Rejeski WJ.

J Am Geriatr Soc. 2013 Jul;61(7):1089-94. doi: 10.1111/jgs.12321. Epub 2013 Jun 17.

48.

Comparison of standardized clinical classification with fundus photograph grading for the assessment of diabetic retinopathy and diabetic macular edema severity.

Gangaputra S, Lovato JF, Hubbard L, Davis MD, Esser BA, Ambrosius WT, Chew EY, Greven C, Perdue LH, Wong WT, Condren A, Wilkinson CP, Agrón E, Adler S, Danis RP; ACCORD Eye Research Group.

Retina. 2013 Jul-Aug;33(7):1393-9. doi: 10.1097/IAE.0b013e318286c952.

49.

Intensive glycemic control and thiazolidinedione use: effects on cortical and trabecular bone at the radius and tibia.

Schwartz AV, Vittinghoff E, Margolis KL, Scibora LM, Palermo L, Ambrosius WT, Hue TF, Ensrud KE.

Calcif Tissue Int. 2013 May;92(5):477-86. doi: 10.1007/s00223-013-9703-0. Epub 2013 Feb 5.

50.

Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial.

Gerstein HC, Ambrosius WT, Danis R, Ismail-Beigi F, Cushman W, Calles J, Banerji M, Schubart U, Chew EY; ACCORD Study Group.

Diabetes Care. 2013 May;36(5):1266-71. doi: 10.2337/dc12-1311. Epub 2012 Dec 13.

Supplemental Content

Loading ...
Support Center